FDA Clears Genentech's Tarceva for Lung Cancer
550215
Biotechnology companies Genentech  Inc. and OSI Pharmaceuticals Inc. on Thursday said U.S.  regulators have approved their drug Tarceva for treating the  most common form of lung cancer.
295886
The U.S. Food and Drug  Administration said on Wednesday it had approved Amgen Inc's  drug Vectibix for the treatment of advanced colon cancer.
188330
Pharmaceutical firm Wyeth said Tuesday that the Food and Drug Administration granted fast-track status to its experimental cancer drug temsirolimus as an initial treatment for patients with advanced kidney ...
758098
German drugmaker Schering AG said on  Thursday that the U.S. Food and Drug Administration had granted  its breast cancer treatment bonefos "priority review" status.
36374
The FDA has approved the drug letrozole for use in postmenopausal women with early breast cancer who have completed standard adjuvant tamoxifen therapy.
630746
Genentech Inc. and Swiss drug maker Roche Holding AG said Monday that a recent study showed their colon cancer drug Avastin significantly extended patient survival when combined with an oxaliplatin-based chemotherapy drug.
118432
The US Food and Drug Administration (FDA) has approved the Eli Lilly drug Alimta, for the treatment of advanced non-small cell lung cancer in previously treated patients.
44693
Celera Genomics Group of Rockville announced an agreement Tuesday to provide potential targets for cancer drugs to biotech giant Genentech Inc. -The Washington Post
681279
Genentech Inc said on Tuesday its cancer drug, Avastin, met the primary goal of prolonging progression-free survival when combined with chemotherapy in a breast cancer study, sending its shares up more than 3 percent.
738230
Genentech and OSI Pharmaceuticals won federal approval yesterday to sell Tarceva, a pill to treat lung cancer.
668214
WASHINGTON The Food and Drug Administration has approved a drug designed to better fight what&#39;s described as the leading cause of cancer-related deaths in America.
550498
German drug maker Schering AG was  boosted on Thursday as the U.S. Food and Drug Administration  granted its Bonefos treatment "priority review" for preventing  bone tumors in breast cancer patients.
263089
A Merck &amp; Co. Inc. drug received federal approval Friday to treat a slow-growing cancer that affects infection-fighting white blood cells.
493049
U.S. health regulators on Wednesday approved Wyeth's drug Torisel for patients with an advanced form of kidney cancer called renal cell carcinoma, saying it helped them live longer.
171991
U.S. health regulators on Wednesday  approved Wyeth&#39;s drug Torisel for patients with an advanced  form of kidney cancer called renal cell carcinoma, saying it  significantly helped them live longer.
350586
SAN FRANCISCO - A novel colon cancer-fighting drug developed by Genentech Inc. already on its way to blockbuster status got an additional boost Monday when the company announced Avastin helped some of the
249246
Genentech and Biogen Idec's drug shows positive results against multiple sclerosis.